In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report). The company’s ...
Truist Financial analyst Nicole Germino maintained a Buy rating on Insmed (INSM – Research Report) today. The company’s shares closed yesterday ...
Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.
Auburn remained in a tie for first place in the Sangamo Conference and extended its current win streak to 12 with hard-fought wins over Riverton (58-44) and Athens (68-52) last week. The final scores ...
RICHMOND, Calif. - Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company with a market capitalization of $263 million, has announced promising updated results from its Phase 1/2 STAAR ...
Allergan Aesthetics, an AbbVie company , announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have ...
Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored ...
Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Biogen Inc. or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
The Paxton-Buckley-Loda varsity girls basketball team won 53-36 over Riverton in the Illini Prairie/Sangamo Conference Shootout on Saturday. Tanner Graham finished with 14 points and would be named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results